GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adcock Ingram Holdings Ltd (JSE:AIP) » Definitions » 3-Year EPS without NRI Growth Rate

Adcock Ingram Holdings (JSE:AIP) 3-Year EPS without NRI Growth Rate : 14.10% (As of Dec. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Adcock Ingram Holdings 3-Year EPS without NRI Growth Rate?

Adcock Ingram Holdings's EPS without NRI for the six months ended in Dec. 2024 was R2.59.

During the past 12 months, Adcock Ingram Holdings's average EPS without NRI Growth Rate was 4.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was 14.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 8.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 9.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Adcock Ingram Holdings was 24.30% per year. The lowest was -24.60% per year. And the median was 2.55% per year.


Competitive Comparison of Adcock Ingram Holdings's 3-Year EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Adcock Ingram Holdings's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adcock Ingram Holdings's 3-Year EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Adcock Ingram Holdings's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Adcock Ingram Holdings's 3-Year EPS without NRI Growth Rate falls into.


;
;

Adcock Ingram Holdings 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Adcock Ingram Holdings  (JSE:AIP) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Adcock Ingram Holdings 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Adcock Ingram Holdings's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Adcock Ingram Holdings Business Description

Traded in Other Exchanges
N/A
Address
1 New Road, (c/o New Road & 7th Street), Midrand, Johannesburg, GT, ZAF, 1682
Adcock Ingram Holdings Ltd is a drug manufacturing company. The company manufactures, markets, and distributes a wide range of healthcare products. The company's reportable segment include Consumer, OTC, Prescription, Hospital and Other-shared services, out of which it generates maximum revenue from Prescription segment. Geographically it operates in Southern Africa and India.